Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study.
Saliba F, De Simone P, Nevens F, De Carlis L, Metselaar HJ, Beckebaum S, Jonas S, Sudan D, Fischer L, Duvoux C, Chavin KD, Koneru B, Huang MA, Chapman WC, Foltys D, Dong G, Lopez PM, Fung J, Junge G; H2304 Study Group. Saliba F, et al. Among authors: dong g. Am J Transplant. 2013 Jul;13(7):1734-45. doi: 10.1111/ajt.12280. Epub 2013 May 28. Am J Transplant. 2013. PMID: 23714399 Free article. Clinical Trial.
Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study.
Fischer L, Saliba F, Kaiser GM, De Carlis L, Metselaar HJ, De Simone P, Duvoux C, Nevens F, Fung JJ, Dong G, Rauer B, Junge G; H2304 Study Group. Fischer L, et al. Among authors: dong g. Transplantation. 2015 Jul;99(7):1455-62. doi: 10.1097/TP.0000000000000555. Transplantation. 2015. PMID: 26151607 Clinical Trial.
Effect of Early Everolimus-Facilitated Reduction of Tacrolimus on Efficacy and Renal Function in De Novo Liver Transplant Recipients: 24-Month Results for the North American Subpopulation.
Chapman WC, Brown RS Jr, Chavin KD, Sudan D, Koneru B, Junge G, Dong G, Patel D, Teperman L, Fung JJ. Chapman WC, et al. Among authors: dong g. Transplantation. 2017 Feb;101(2):341-349. doi: 10.1097/TP.0000000000001524. Transplantation. 2017. PMID: 28121741 Free PMC article. Clinical Trial.
Everolimus versus mycophenolate mofetil in heart transplantation: a randomized, multicenter trial.
Eisen HJ, Kobashigawa J, Starling RC, Pauly DF, Kfoury A, Ross H, Wang SS, Cantin B, Van Bakel A, Ewald G, Hirt S, Lehmkuhl H, Keogh A, Rinaldi M, Potena L, Zuckermann A, Dong G, Cornu-Artis C, Lopez P. Eisen HJ, et al. Among authors: dong g. Am J Transplant. 2013 May;13(5):1203-16. doi: 10.1111/ajt.12181. Epub 2013 Feb 22. Am J Transplant. 2013. PMID: 23433101 Free article. Clinical Trial.
Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation.
Langer RM, Hené R, Vitko S, Christiaans M, Tedesco-Silva H Jr, Ciechanowski K, Cassuto E, Rostaing L, Vilatoba M, Machein U, Ulbricht B, Junge G, Dong G, Pascual J. Langer RM, et al. Among authors: dong g. Transpl Int. 2012 May;25(5):592-602. doi: 10.1111/j.1432-2277.2012.01465.x. Epub 2012 Mar 26. Transpl Int. 2012. PMID: 22471345 Free article. Clinical Trial.
Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.
Kobashigawa JA, Pauly DF, Starling RC, Eisen H, Ross H, Wang SS, Cantin B, Hill JA, Lopez P, Dong G, Nicholls SJ; A2310 IVUS Substudy Investigators. Kobashigawa JA, et al. Among authors: dong g. JACC Heart Fail. 2013 Oct;1(5):389-99. doi: 10.1016/j.jchf.2013.07.002. Epub 2013 Sep 11. JACC Heart Fail. 2013. PMID: 24621971 Free article. Clinical Trial.
3,638 results